Clinical Trial Update: Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BCG vaccination for prevention of COVID-19 via enhanced innate immunity in health care workers; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection
• Viral Infection

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Infection, Viral, Agent as Cause of Disease Classified Elsewhere | Phase 3 | Status: UNKNOWN